Preferential Generation of Killer or Helper T-lymphocyte Activity Directed to the Tumour-associated Transplantation Antigens
Overview
Authors
Affiliations
Induction of killer and helper T-cell activities towards transplantation antigens of two tumour cell lines was analysed in the allogeneic and syngeneic host combinations. The lymphoid cells from C57BL/6 mice immunized with allogeneic viable or mitomycin C-treated X-5563 plasmacytoma cells derived from C3H/He mice revealed both killer and helper T-cell activities against alloantigens, whereas cells from mice immunized with tumour cells killed by a freezing and thawing procedure revealed predominantly helper T-cell activity. On the other hand, when C3H/He mice were immunized with viable syngeneic X-5563 plasmacytoma or MM102 mammary tumour cells, the former generated preferentially killer T-cell activity, whereas the latter induced predominantly helper T-cell activity against tumour-associated transplantation antigens. Thus, immunization with transplantation antigen(s) does not always induce both helper and killer T-cell activities in parallel, but a certain antigenic system induces predominantly one type of T-cell response, thus indicating that two distinct subsets of helper and killer T cells against the transplantation antigen(s) can be raised independently without an absolute requirement of collaboration between these different T-cells subsets.
Yoshioka T, Fujiwara H, Takai Y, Ogata M, Shimizu J, Hamaoka T Cancer Immunol Immunother. 1987; 24(1):8-12.
PMID: 3493074 PMC: 11038293. DOI: 10.1007/BF00199826.
Effect of recombinant interleukin 2 (R-IL2) on in vivo growth of murine myeloma X5563.
Maekawa R, Matsumoto M, Kitagawa T, Harada M, Sato K Cancer Immunol Immunother. 1986; 23(1):25-30.
PMID: 3490306 PMC: 11038606. DOI: 10.1007/BF00205551.
Sakamoto K, Nakajima H, Shimizu J, Katagiri T, Kiyotaki C, Fujiwara H Cancer Immunol Immunother. 1988; 27(3):261-6.
PMID: 3141057 PMC: 11038580. DOI: 10.1007/BF00205449.
Nakajima H, Izumi Y, Sugihara S, Satoh Y, Isumi S, Gotoh T Cancer Immunol Immunother. 1987; 25(3):201-8.
PMID: 3119213 PMC: 11038001. DOI: 10.1007/BF00199148.
Hamaoka T, Fujiwara H, Teshima K, Aoki H, Yamamoto H, Kitagawa M J Exp Med. 1979; 149(1):185-99.
PMID: 310858 PMC: 2184739. DOI: 10.1084/jem.149.1.185.